ATG4B and neoplasm: Further studies in Figure 6B show that knockout of ATG4B could reduce the sensitivity of tumor cells to 163N treatment, implying that 163N might partially target ATG4B in cells, and this factor may also contribute to the increase of autolysosome induced by 163N treatment.